IP Verse

Hamm&wittkopp Patentanwalte Partmbb patent opposition analysis

Get complete Patent Opposition Report for Hamm&wittkopp Patentanwalte Partmbb

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Hamm&wittkopp Patentanwalte Partmbb

Explore patent oppositions filed by Hamm&wittkopp Patentanwalte Partmbb against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3217983Enhancement Of Tumor Response To Chemotherapy By Activation Of The Asmase/Ceramide Pathway Through Timed Administration Of A Short-Acting Anti-Angiogenic AgentMEMORIAL SLOAN KETTERING CANCER CENTERJan 31, 2025
EP3090730Novel Pharmaceutical CompositionNOVARTISJan 10, 2025
EP3494961Compositions And Methods For Treating Chronic Inflammation And Inflammatory DiseasesINFIRST HEALTHCAREJan 10, 2025
EP3711758Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence SeizureSK BIOPHARMACEUTICALSDec 13, 2024
EP3393600Sun Care Composition Based On Small Particle O/W EmulsionALAMNov 21, 2024
EP4159204Novel Pharmaceutical CompositionNOVARTISNov 11, 2024
EP4159205Novel Pharmaceutical CompositionNOVARTISNov 11, 2024
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024
EP4025188Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJANSSEN PHARMACEUTICAOct 9, 2024
EP4025187Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJANSSEN PHARMACEUTICAOct 4, 2024

Top competitors of Hamm&wittkopp Patentanwalte Partmbb